BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32017049)

  • 1. Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.
    Kok END; Havenga K; Tanis PJ; de Wilt JHW; Hagendoorn J; Peters FP; Buijsen J; Rutten HJT; Kuhlmann KFD;
    Br J Surg; 2020 Apr; 107(5):537-545. PubMed ID: 32017049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases.
    Li R; Wang Q; Zhang B; Yuan Y; Xie W; Huang X; Zhou C; Zhang S; Niu S; Chang H; Chen D; Miao H; Zeng ZF; Xiao W; Gao Y
    BMC Cancer; 2021 Dec; 21(1):1333. PubMed ID: 34906114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival.
    Labori KJ; Guren MG; Brudvik KW; Røsok BI; Waage A; Nesbakken A; Larsen S; Dueland S; Edwin B; Bjørnbeth BA
    Colorectal Dis; 2017 Aug; 19(8):731-738. PubMed ID: 28181384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stage IV rectal cancer with liver metastases: is there a benefit to resection of the primary tumor?
    Cellini C; Hunt SR; Fleshman JW; Birnbaum EH; Bierhals AJ; Mutch MG
    World J Surg; 2010 May; 34(5):1102-8. PubMed ID: 20177683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Toppan P; Rugge M; Sinigaglia G; Nitti D; Sotti G; Monfardini S
    Anticancer Res; 2007; 27(2):1079-85. PubMed ID: 17465247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
    Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of preoperative mFOLFOX6 with short-course radiotherapy in patients with locally advanced rectal cancer and liver-only metastasis.
    Kim KH; Shin SJ; Cho MS; Ahn JB; Jung M; Kim TI; Park YS; Kim H; Kim NK; Koom WS
    Radiother Oncol; 2016 Feb; 118(2):369-74. PubMed ID: 26705682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR; Benedetti JK; Williamson SK; Robertson JM; Estes NC; Maher T; Fisher B; Rich TA; Martenson JA; Kugler JW; Benson AB; Haller DG; Mayer RJ; Atkins JN; Cripps C; Pedersen J; Periman PO; Tanaka MS; Leichman CG; Macdonald JS
    J Clin Oncol; 2006 Aug; 24(22):3542-7. PubMed ID: 16877719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report.
    Lee JH; Lee JH; Ahn JH; Bahng H; Kim TW; Kang YK; Lee KH; Kim JC; Yu CS; Kim JH; Ahn SD; Kim WK; Kim SH; Lee JS
    J Clin Oncol; 2002 Apr; 20(7):1751-8. PubMed ID: 11919231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
    Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
    J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of adjuvant pelvic radiotherapy in rectal cancer with synchronous liver metastasis: a retrospective study.
    Kim JW; Kim YB; Kim NK; Min BS; Shin SJ; Ahn JB; Koom WS; Seong J; Keum KC
    Radiat Oncol; 2010 Aug; 5():75. PubMed ID: 20804559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant radiation therapy in resectable rectal cancer: should local recurrence rates affect the decision?
    Kim NK; Senagore AJ; Luchtefeld MA; MacKeigan JM; Mazier WP; Belknap K
    Am Surg; 1997 Jul; 63(7):579-84; discussion 584-5. PubMed ID: 9202530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.
    Cho H; Kim JE; Kim KP; Yu CS; Kim JC; Kim JH; Lee MA; Jang HS; Oh ST; Kim SY; Oh JH; Kim DY; Hong YS; Kim TW
    Am J Clin Oncol; 2016 Dec; 39(6):623-629. PubMed ID: 27322695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neoadjuvant treatment in cT3N0M0 rectal cancer.
    Pasetto LM; Friso ML; Pucciarelli S; Basso U; Rugge M; Sinigaglia G; Rossi E; Compostella A; Toppan P; Agostini M; Monfardini S
    Anticancer Res; 2008; 28(6B):4129-35. PubMed ID: 19192672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.